ZFHX4 mutation as a novel predictive biomarker for immune checkpoint blockade in non-small cell lung cancer.

被引：0
|
作者：
Shen, Peng
Zeng, Di
Lin, Zhenzi
Lin, Pei
Luo, Mingyang
Zhao, Lele
Chai, Huizi
Huang, Lingli
Xiao, Mingzhe
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Clin Med Sch 1, Guangzhou, Peoples R China
[3] Jiangsu Sim cere Diagnost Co Ltd, State Key Lab Translat Med & Innovat Drug Dev, Jiangsu Simcere Diagnost Co, Nanjing, Peoples R China
[4] Jiangsu Simcere Diagnost Co Ltd, Dept Med, Nanjing, Peoples R China
[5] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20535
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Ka
    Gabrielson, Edward
    Brock, Malcolm
    Zahnow, Cynthia
    Baylin, Stephen B.
    Scharpf, Rob
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    CANCER RESEARCH, 2017, 77
  • [32] Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non-small Cell Lung Cancer
    Lo Russo, Giuseppe
    Facchinetti, Francesco
    Tiseo, Marcello
    Garassino, Marina Chiara
    Ferrara, Roberto
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)
  • [33] Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?
    Califano, R.
    Gomes, F.
    Ackermann, C. J.
    Rafee, S.
    Tsakonas, G.
    Ekman, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 1 - 11
  • [34] Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios
    Tay, Rebecca
    Prelaj, Arsela
    Califano, Raffaele
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1494 - S1502
  • [35] Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Zhang, Theresa
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Kay
    Gabrielson, Edward
    Brock, Malcolm V.
    Zahnow, Cynthia A.
    Baylin, Stephen B.
    Scharpf, Robert B.
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    CANCER DISCOVERY, 2017, 7 (03) : 264 - 276
  • [36] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [37] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
  • [38] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [39] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [40] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
12345